Fig. 2: Survival contribution of ICPs across multiple cancer types. | npj Precision Oncology

Fig. 2: Survival contribution of ICPs across multiple cancer types.

From: Genomic investigation of co-targeting tumor immune microenvironment and immune checkpoints in pan-cancer immunotherapy

Fig. 2

a Contribution of ICPs to OS in multiple cancer types. GEPIA generated the Kaplan–Meier OS map comparing the groups with different expression levels of ICPs in multiple cancer types (TCGA tumors). b Contribution of ICPs to DFS in multiple cancer types. GEPIA generates the Kaplan–Meier DFS map comparing the groups with different expression levels of ICPs in multiple cancer types (TCGA tumors). Red blocks represent ICPs unfavorable to survival, blue blocks represent ICPs favorable to survival, and the ones with outer wireframe indicate significant influence. Mantel–Cox test was used for the hypothesis tests, and the Cox proportional hazard ratio was included in the survival plots. A p value < 0.05 was considered to be statistically significant.

Back to article page